Severity of osteoporosis: What is the impact of co-morbidities?

Joint Bone Spine

Volumn 77, Issue SUPPL. 2, 2010, Pages

  David, Claire ^a   Confavreux, Cyrille B ^b   Mehsen, Nadia ^c   Paccou, Julien ^d   Leboime, Ariane ^e   Legrand, Erick ^f  

^a SERVICE DE RHUMATOLOGIE   (France)

^b UNIVERSITÉ DE LYON   (France)

^c HÔPITAL PELLEGRIN   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f UNIVERSITÉ D'ANGERS   (France)

Author keywords

Co morbidity; Fractures; Health conditions; Risk factors; Severe osteoporosis

Indexed keywords

GLUCOCORTICOID;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CELIAC DISEASE; CHRONIC ARTHRITIS; CLINICAL TRIAL (TOPIC); COMORBIDITY; DEPRESSION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENTERITIS; FRACTURE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MEDICAL DECISION MAKING; OSTEOPOROSIS; POSTMENOPAUSE; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; STEROID THERAPY;

EID: 78650742529     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1297-319X(10)70003-8     Document Type: Article

References (35)

1. Cauley J.A., Wu L., Wampler N.S., et al. Clinical risk factors for fractures in multi-ethnic women: the Women's Health Initiative. J Bone Miner Res 2007, 22:1816-1826.
2. Kanis J.A., Borgstrom F., De Laet C., et al. Assessment of fracture risk. Osteoporos Int 2005, 16:581-589.
3. Fardellone P. Predicting the fracture-risk in 2008. Joint Bone Spine 2008, 75:661-664.
4. Van der Klift M., De Laet C.E., McCloskey E.V., et al. The incidence of vertebral fractures in men and women: the Rotterdam Study. J Bone Miner Res 2002, 17:1051-1056.
5. Kanis J.A., Johnell O., Oden A., et al. Smoking and fracture risk: a meta-analysis. Osteoporos Int 2005, 16:155-162.
6. Kanis J., Oden A., Johnell O. Acute and long-term increase in fracture risk after hospitalization for stroke. Stroke 2001, 32:702-706.
7. Card T., West J., Hubbard R., et al. Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study. Gut 2004, 53:251-255.
8. Vestergaard P., Krogh K., Rejnmark L., et al. Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut 2000, 46:176-181.
9. Bernstein C.N., Blanchard J., Leslie W., et al. The incidence of fracture among patients with inflammatory bowel disease. Ann Intern Med 2000, 133:795-799.
10. Stockbrügger R.W., Schoon E.J., Bollani S., et al. Discordance between the degree of osteopenia and the prevalence of spontaneous verttebral fractures in cohn's disease. Aliment Pharmacol Ther 2002, 16:1519-1527.
11. Van Staa T.P., Geusens P., Bijlsma W.J., et al. Clinical assessment of the long-term risk of fracture in patients with Rheumatoid arthritis. Arthritis Rheum 2006, 54:3104-3112.
12. Legroux-Gérot I., Leloire O., Blanckaert, et al. Screening for celiac disease in patients with osteoporosis. Joint Bone Spine 2009, 76:162-165.
13. Olmos M., Antelo M., Vazquez H., et al. Systematic review and meta-analysis of observational studies on the prevalence of fractures in coeliac disease. Dig Liver Dis 2008, 40:46-53.
14. Davie M.W., Gaywood I., George E., et al. Excess non-spine fractures in women over 50 years with coeliac disease: a cross-sectional, questionnaire-based study. Osteoporos Int 2005, 16:1150-1155.
15. Kanis J.A., McCloskey E.V., Powles T., et al. A high incidence of vertebral fracture in women with breast cancer. Br J Cancer 1999, 79:1179-1181.
16. Fontanges E., Fontana A., Delmas P. Osteoporosis and breast cancer. Joint Bone Spine 2004, 71:102-110.
17. Aapro M.S. Long-term implications of bone loss in breast cancer. Breast 2004, 13:29-37.
18. Mackey J.R., Joy A.A. Skeletal health in postmenopausal survivors of early breast cancer. Int J Cancer 2005, 114:1010-1015.
19. Taylor L.G., Canfield S.E., Du X.L. Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer. Cancer 2009, 115:2388-2399.
20. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes - a meta-analysis. Osteoporos Int 2007, 18:427-444.
21. Janghorbani M., Van Dam R.M., Willett W.C., et al. Systematic review of type 1 and type 2 Diabetes mellitus and risk of fracture. Am J Epidemiol 2007, 166:495-505.
22. Bonds D.E., Larson J.C., Schwartz A.V., et al. Risk of fracture in women with type 2 diabetes: the women's health initiative observational study. J Clin Endocrinol Metab 2006, 91:3404-3410.
23. Johnell O., Kanis J.A., Black D.M., et al. Associations between baseline risk factors and vertebral fracture risk in the multiple outcomes of Raloxifene evaluation (MORE) study. J Bone Miner Res 2004, 19:764-772.
24. Forsén L., Meyer H.E., Sogaard A.J., et al. Mental distress and risk of hip fracture. Do broken hearts lead to broken bones?. J Epidemiol Community Health 1999, 53:343-347.
25. Mussolino M.E. Depression and hip fracture risk: the NHANES I epidemiologic follow-up study. Public Health Rep 2005, 120:71-75.
26. Søgaard A.J., Joakimsen R.M., Tverdal A., et al. Long-term mental distress, bone mineral density and non-vertebral fractures. The Tromsø Study. Osteoporos Int 2005, 16:887-897.
27. Whooley M.A., Kip K.E., Cauley J.A., et al. Depression, falls, and risk of fracture in older women. Study of Osteoporotic Fractures Research Group. Arch Intern Med 1999, 159:484-490.
28. Wu Q., Liu J., Gallegos-Orozco J.F. Depression, fracture risk, and bone loss: a meta-analysis of cohort studies. Osteoporos Int 2010, 4. Mar 4 [Epub ahead of print].
29. Alem A.M., Sherrard D.J., Gillen D.L., et al. Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 2000, 58:396-399.
30. Ensrud K.E., Shlipak M.G., Jamal S.A. Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med 2007, 167:133-139.
31. Dukas L., Schacht E., Stähelin H.B. In elderly men and women treated for osteoporosis a low creatinine clearance of < 65 ml/mn is a risk factor for falls and fractures. Osteoporos Int 2005, 16:1683-1690.
32. Miller P.D., Roux C., Boonen S., et al. Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockroft and Gault method: a pooled analysis of nine clinical trials. J Bone Miner Res 2005, 20:2105-2115.
33. Jamal S.A., Bauer D.C., Ensrud K.E., et al. Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial. J Bone Miner Res 2007, 22:503-508.
34. Briot K., Cortet B., Trémollières F., et al. Male osteoporosis: Diagnosis and fracture risk evolution. Joint Bone Spine 2009, 76:129-133.
35. Legrand E., Audran M., Guggenbuhl P., et al. Trabecular bone microarchitecture is related to the number of risk factors and etiology in osteoporotic men. Microsc Res Tech 2007, 70:952-959.